Arena Pharmaceuticals Inc
ARNA
ARNA was delisted on the 10th of March, 2022.
129 hedge funds and large institutions have $628M invested in Arena Pharmaceuticals Inc in 2014 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 33 increasing their positions, 44 reducing their positions, and 21 closing their positions.
3% less capital invested
Capital invested by funds: $645M → $628M (-$16.9M)
10% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 21
2% less funds holding
Funds holding: 131 → 129 (-2)
25% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 44
47% less call options, than puts
Call options by funds: $22.8M | Put options by funds: $43.1M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$19.9M |
| 2 |
Norges Bank
Oslo,
Norway
|
+$13.7M |
| 3 |
Morgan Stanley
New York
|
+$8.89M |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$4.34M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$6.18M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$4.12M |
| 3 |
Goldman Sachs
New York
|
-$3.68M |
| 4 |
State Street
Boston,
Massachusetts
|
-$3.57M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$3.21M |
ARNA Hedge Fund Activity: Q2 2014 in Review
129 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q2 2014, worth a combined $628M — down 2.6% from $645M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of ARNA and 19 opened new positions — a net loss of 2 holders — while 44 trimmed existing stakes and 33 added.
The largest buyer was Deerfield Management, adding an estimated $19.9M. The largest seller was BlackRock Advisors, cutting an estimated $6.18M.
- 129 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q2 2014, down from 131 in Q1 2014.
- Funds reported $628M of Arena Pharmaceuticals Inc stock for Q2 2014, down 2.6% quarter-over-quarter.
- 19 funds opened new Arena Pharmaceuticals Inc positions in Q2 2014 and 21 closed out, a net change of -2 holders.
- The largest Arena Pharmaceuticals Inc buyer in Q2 2014 was Deerfield Management, an estimated $19.9M added.
- The largest Arena Pharmaceuticals Inc seller in Q2 2014 was BlackRock Advisors, an estimated $6.18M sold.
Based on aggregated 13F filings for Q2 2014.